Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial

Chaitman, Bernard R.; Rosen, Allan D.; Williams, David O.; Bourassa, Martial G.; Aguirre, Frank V.; Pitt, Bertram; Rautaharju, Pentti M.; Rogers, William J.; Sharaf, Barry L.; Attubato, Michael; Hardison, Regina M.; Srivatsa, Sanjay S.; Kouchoukos, Nicholas T.; Stocke, Karen; Sopko, George; Detre, Katherine M.; Frye, Robert L.

doi:10.1161/01.cir.96.7.2162

Cited by 119 publications

(47 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…two or more years after index admission) mortality for patients receiving CABG versus PTCA. For example, the Bypass Angioplasty Revascularization Investigation (BARI) trial found that, for non-diabetic patients with multivessel disease, there was no significant difference in the 5-year mortality for patients randomized to either CABG or PTCA (Chaitman et al, 1997). For multivessel patients with diabetes, those receiving CABG had significantly lower 5-year mortality than those receiving PTCA.…”

Section: Treatment Substitutionmentioning

confidence: 99%

Technological development and medical productivity: the diffusion of angioplasty in New York state

Cutler¹,

Huckman²

2003

Journal of Health Economics

View full text Add to dashboard Cite

A puzzling feature of many medical innovations is that they simultaneously appear to reduce unit costs and increase total costs. We consider this phenomenon by examining the diffusion of percutaneous transluminal coronary angioplasty (PTCA)-a treatment for coronary artery diseaseover the past two decades. We find that growth in the use of PTCA led to higher total costs despite its lower unit cost. Over the two decades following PTCA's introduction, however, we find that the magnitude of this increase was reduced by between 10 and 20% due to the substitution of PTCA for CABG. In addition, the increased use of PTCA appears to be a productivity improvement. PTCAs that substitute for CABG cost less and have the same or better outcomes, while PTCAs that replace medical management appear to improve health by enough to justify the cost.

show abstract

Section: Treatment Substitutionmentioning

confidence: 99%

Technological development and medical productivity: the diffusion of angioplasty in New York state

Cutler¹,

Huckman²

2003

Journal of Health Economics

View full text Add to dashboard Cite

show abstract

“…For this analysis, the criteria used for diagnosing MI in hospital and during follow-up were similar to the MI definition used for BARI. 11 In the 96 hours after the revascularization procedure, MI was defined as the presence of a new Q wave on the postprocedural ECG; after the 96 hours, Q-wave and non-Q-wave MIs (identified on the basis of enzymes, chest pain, or ECG changes) were counted. Definitions of other end points have been described previously.…”

Section: Definitionsmentioning

confidence: 99%

Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease

et al. 2002

Self Cite

View full text Add to dashboard Cite

Background-This investigation compares the results of contemporary percutaneous coronary intervention (PCI) with standard balloon angioplasty among patients with multivessel coronary disease. By multivariate analysis, contemporary PCI was independently associated with reduced risk for in-hospital CABG, 1-year CABG, and 1-year PCI. Conclusions-Among patients with multivessel disease, contemporary PCI resulted in safer and more durable revascularization. These results support the role of PCI for selected patients with multivessel coronary artery disease.

show abstract

“…12 As the applicability of PCI expanded, randomised data showed that surgical and percutaneous revascularisation were equivalent in terms of both survival and future risk of MI. 13 The latter strategy, however, would incorporate a greater likelihood of requiring a further intervention because of restenosis, but the introduction of routine stenting 14 -particularly with drug-eluting devices 15 -soon eroded this difference.…”

Section: The Evidence Basementioning

confidence: 99%

Cardiac service provision in the United Kingdom

Norell¹

2007

Clinical Medicine

View full text Add to dashboard Cite

-Cardiac conditions account for at least half of acute medical admissions. The provision of a comprehensive and responsive cardiological service in the UK is therefore pivotal to the manner in which the NHS continues to modernise. This article reviews recent developments in cardiology, describes the current provision of cardiac services for the more commonly encountered conditions, and explores future developments that will impact on the care patients presenting with heart disease receive.

show abstract

Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial

Cited by 119 publications

References 28 publications

Technological development and medical productivity: the diffusion of angioplasty in New York state

Technological development and medical productivity: the diffusion of angioplasty in New York state

Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease

Cardiac service provision in the United Kingdom

Contact Info

Product

Resources

About